Tower Research Capital (TRC)’s Immunovant, Inc. Units IMVTU Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMVTU Stock Details IMVTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-156	Closed	-$3K	–	5170
2020 Q1	$3K	Hold	156	–	–	﹤0.01%	2533
2019 Q4	$4K	Buy	+156	New	+$3.36K	﹤0.01%	2857

Tower Research Capital (TRC)'s IMVTU Position: Q2 2020 in Review

Tower Research Capital (TRC) sold out of Immunovant, Inc. Units (IMVTU) in Q2 2020, closing a stake of 156 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in IMVTU in Q4 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2019. 0 funds tracked by Wall St. Rank hold IMVTU as of Q2 2020.

Tower Research Capital (TRC) reported no remaining Immunovant, Inc. Units position as of Q2 2020 after selling out during the quarter.
Tower Research Capital (TRC) sold 156 Immunovant, Inc. Units shares in Q2 2020, an estimated $3K.
Tower Research Capital (TRC) first reported a position in Immunovant, Inc. Units in Q4 2019 and held it in 2 quarters.
Tower Research Capital (TRC)'s Immunovant, Inc. Units position peaked at $4K in Q4 2019.
0 funds tracked by Wall St. Rank held Immunovant, Inc. Units as of Q2 2020.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.